PTC
IBB icon

Private Trust Company’s iShares Biotechnology ETF IBB Stock Holding History

Private Trust Company’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Sell
558
-407
-42% -$70K 0.01% 1055
2026
Q1 		$163K Sell
965
-349
-27% -$59.7K 0.01% 855
2025
Q4 		$222K Buy
1,314
+826
+169% +$134K 0.02% 724
2025
Q3 		$70.5K Buy
488
+86
+21% +$11.7K 0.01% 1134
2025
Q2 		$50.9K Sell
402
-51
-11% -$6.26K ﹤0.01% 1213
2025
Q1 		$57.9K Sell
453
-160
-26% -$21.7K 0.01% 1135
2024
Q4 		$81K Sell
613
-2,883
-82% -$405K 0.01% 996
2024
Q3 		$509K Sell
3,496
-17
-0.5% -$2.46K 0.05% 378
2024
Q2 		$482K Buy
3,513
+2,439
+227% +$326K 0.05% 380
2024
Q1 		$147K Sell
1,074
-19
-2% -$2.6K 0.02% 741
2023
Q4 		$148K Sell
1,093
-4,000
-79% -$488K 0.02% 705
2023
Q3 		$623K Sell
5,093
-194
-4% -$24.7K 0.08% 272
2023
Q2 		$671K Hold
5,287
– – 0.08% 262
2023
Q1 		$683K Sell
5,287
-278
-5% -$36.4K 0.09% 251
2022
Q4 		$731K Buy
5,565
+80
+1% +$10.3K 0.11% 220
2022
Q3 		$642K Buy
5,485
+1,094
+25% +$136K 0.1% 224
2022
Q2 		$517K Sell
4,391
-2,594
-37% -$308K 0.08% 270
2022
Q1 		$910K Buy
6,985
+728
+12% +$94.8K 0.14% 166
2021
Q4 		$955K Sell
6,257
-90
-1% -$13.9K 0.13% 171
2021
Q3 		$1.03M Buy
6,347
+700
+12% +$118K 0.15% 164
2021
Q2 		$924K Buy
5,647
+82
+1% +$12.6K 0.14% 171
2021
Q1 		$837K Sell
5,565
-150
-3% -$23.8K 0.14% 180
2020
Q4 		$865K Sell
5,715
-887
-13% -$127K 0.15% 163
2020
Q3 		$893K Buy
6,602
+23
+0.3% +$3.12K 0.17% 147
2020
Q2 		$911K Sell
6,579
-146
-2% -$18.6K 0.19% 133
2020
Q1 		$724K Buy
6,725
+410
+6% +$47.2K 0.19% 128
2019
Q4 		$761K Hold
6,315
– – 0.14% 159
2019
Q3 		$628K Buy
6,315
+283
+5% +$29.6K 0.12% 194
2019
Q2 		$658K Sell
6,032
-138
-2% -$14.7K 0.13% 179
2019
Q1 		$689K Hold
6,170
– – 0.14% 164
2018
Q4 		$594K Buy
6,170
+1,054
+21% +$112K 0.14% 168
2018
Q3 		$623K Hold
5,116
– – 0.13% 199
2018
Q2 		$561K Buy
5,116
+188
+4% +$20.1K 0.12% 203
2018
Q1 		$526K Buy
4,928
+390
+9% +$43.2K 0.12% 217
2017
Q4 		$484K Buy
4,538
+284
+7% +$30.4K 0.1% 235
2017
Q3 		$473K Buy
4,254
+93
+2% +$9.94K 0.1% 236
2017
Q2 		$430K Buy
4,161
+672
+19% +$66.2K 0.09% 258
2017
Q1 		$341K Sell
3,489
-1,596
-31% -$153K 0.08% 283
2016
Q4 		$449K Buy
5,085
+591
+13% +$53.8K 0.11% 222
2016
Q3 		$433K Sell
4,494
-108
-2% -$10.3K 0.11% 219
2016
Q2 		$393K Buy
4,602
+27
+0.6% +$2.42K 0.1% 225
2016
Q1 		$397K Sell
4,575
-3,693
-45% -$330K 0.11% 216
2015
Q4 		$931K Buy
8,268
+663
+9% +$72K 0.27% 100
2015
Q3 		$768K Buy
7,605
+1,008
+15% +$121K 0.23% 119
2015
Q2 		$810K Buy
6,597
+309
+5% +$37K 0.23% 124
2015
Q1 		$719K Sell
6,288
-93
-1% -$10.3K 0.21% 133
2014
Q4 		$645K Buy
+6,381
New +$620K 0.2% 131
2013
Q4 		– Sell
-504
Closed -$35K – 1781
2013
Q3 		$35K Hold
504
– – 0.02% 507
2013
Q2 		$29K Buy
+504
New +$29.1K 0.01% 528

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Private Trust Company's IBB Position: Q2 2026 in Review

Private Trust Company reduced its iShares Biotechnology ETF (IBB) stake by 42% in Q2 2026, selling an estimated $70K and leaving 558 shares worth $106K. The position accounts for 0.01% of the portfolio, ranked #1055.

Private Trust Company first reported a position in IBB in Q2 2013 and has held it in 49 quarters since. The position peaked at $1.03M in Q3 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Private Trust Company held 558 shares of iShares Biotechnology ETF worth $106K as of Q2 2026.
  • Private Trust Company sold 407 iShares Biotechnology ETF shares in Q2 2026, an estimated $70K.
  • iShares Biotechnology ETF made up 0.01% of Private Trust Company's portfolio in Q2 2026, its #1055 holding.
  • Private Trust Company first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 49 quarters since.
  • Private Trust Company's iShares Biotechnology ETF position peaked at $1.03M in Q3 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.